CLINICAL_TRIALS
trial_result
· 2019-03-14
Clinical Trial Update: Intraoperative Low-dose Ketamine Infusion as the Main Analgesic in Burn Patients [Phase 4]
Summary
Phase 4 clinical trial evaluating low-dose ketamine infusion as the main analgesic in burn patients.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Loyola University | Conditions: Burns | Phase 4 | Status: UNKNOWN